Hit enter to search or ESC to close
IDEAYA Biosciences
  • Company
    • Company Overview
    • Leadership Team
    • Scientific Advisory Board
    • Board of Directors
    • Partners
    • Investors
  • Science
    • Introduction
    • Biomarker Translational Platform
    • Targeted Therapies
    • Synthetic Lethality
    • Synthetic Lethality Target Discovery Platform
    • Immuno-Oncology
    • References
  • Pipeline
    • Overview
    • PKC (IDE196)
    • Synthetic Lethality Pipeline
    • AhR (IDE697)
  • Newsroom
  • Careers
  • Contact
    • General Inquiries
    • Partnership Inquiries
    • News Alerts
IDEAYA Biosciences
In the News

$94M series B funds bright ‘Ideaya’ in synthetic lethality [via BioWorld]

By IDEAYA Biosciences March 16, 2018 March 22nd, 2018 No Comments

$94M series B funds bright ‘Ideaya’ in synthetic lethality [via BioWorld]

https://www.ideayabio.com/wp-content/uploads/2018/03/94M-series-B-funds-bright-‘Ideaya’-in-synthetic-lethality-BioWorld-Truncated.pdf

© 2019 IDEAYA Biosciences | Terms of Use | Privacy Policy

  • Company
    • Company Overview
    • Leadership Team
    • Scientific Advisory Board
    • Board of Directors
    • Partners
    • Investors
  • Science
    • Introduction
    • Biomarker Translational Platform
    • Targeted Therapies
    • Synthetic Lethality
    • Synthetic Lethality Target Discovery Platform
    • Immuno-Oncology
    • References
  • Pipeline
    • Overview
    • PKC (IDE196)
    • Synthetic Lethality Pipeline
    • AhR (IDE697)
  • Newsroom
  • Careers
  • Contact
    • General Inquiries
    • Partnership Inquiries
    • News Alerts